6 TECH OUTLOOKDecember - 2019EditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comThe emergence of technology has had a remarkable impact on drug discovery and development. Although the underpinning value--medical breakthrough--remains the same, the approach to these medical breakthroughs has undergone augmentation.So far, the pharmaceutical industry has witnessed the entry of technologies like artificial intelligence (AI), machine learning (ML), and data analysis. But, this year we can see several contract research organizations (CRO) make smart investments in the advanced use of these existing technologies. Some tech-vendors are offering detail-oriented models to help pharma companies grapple efficiently with low patient recruitment rates in the market, and some have differentiated clinical trials for various disorders like cancer, depression, and epilepsy, and many more. The results of the in-depth research and development in clinical translational studies to understand the effect of certain high-functioning drugs has left the experts awestruck.Making strides in many such medical realms, technology has also introduced various facets of its own. Advanced clinical laboratories are incorporating robotics for an automated screening to steadfast the entire process of drug discovery, in addition to analytical techniques like mass spectrometry (MS) to determine the identity and structure of un-explored therapeutic molecules.As predicted by the medical experts, the future of clinical trial and monitoring industry seems expansive and fertile. Striving toward this goal with complete rigor, the drug trial industry is traversing through the unexplored territory of pharma-tech to be able to extract the medicinal value of newfound molecules and make patient care more efficient.In this edition of Pharma Tech outlook, we have brought you some of the most proficient industry leaders in the drug trial and development industry that are leveraging their product and expertise to help improve your healthcare vision. We hope this edition proves instrumental to you and your organization.Let us know your thoughts!The Rise of Precision Drug DevelopmentCopyright © 2019 ValleyMedia Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.DECEMBER - 13 - 2019, Vol 05 - Issue 17 (ISSN 2644-2787) Published by ValleyMedia Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com *Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEditor-in-ChiefStacey SmithVisualizerAsher BlakeEditorial StaffAaron Pierce Ava GarciaJenna VegasCarolynn Walters Justin SmithPaul BarberSalesBrian Thomasbrian@pharmatechoutlook.comPhone: 510.556.2402sales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:Contact Us:Phone:510.556.2402, Fax:510-894-8405Albert RozarioTECH OUTLOOKTECH OUTLOOK
< Page 5 | Page 7 >